
To assess the cost-effectiveness, resource use implications, quality-adjusted life years (QALY) and the cost per QALY of care pathways starting with either extracorporeal shockwave lithotripsy (SWL) or with ureteroscopic (URS) retrieval for the management of ureteric stones. The mean QALY difference (SWL vs URS) was –0.021, and the mean cost difference was –£809. The SWL pathway results in lower QALYs than URS but costs less. The incremental cost per QALY is £39,118 cost saving per QALY loss with a 79% probability that SWL would be considered cost‐effective at £30,000 society’s willingness to pay for a QALY threshold and 98% at £20,000 society’s desire to pay for a QALY threshold. Decision‐makers must determine if the costs saved to justify the loss in QALYs.
Like
Save
Share